德国Biotest  
Biotest公司是全球领先的血液和生物制品研发和生产企业，成立于1946年，1987年在法兰克福证券交易所上市，2007年入选德意志交易所SDAX指数。Biotest从血浆中最大限度分离纯化高价值药用成分的能力在全球同类企业中较为突出，其遵循严格的血浆采集、检验和生产规范，产品质量稳定、可靠。Biotest公司与复星医药的合作将有助于缓解中国市场人血白蛋白供应的紧张状况，创造良好的社会效益。


Biotest is a company specialising in innovative haematology and immunology products with the holistic approach of a global pharmaceutical, diagnostics and biotherapeutics group. Its approximately 1,200 employees develop, manufacture and sell medicinal products for the treatment of blood and immune diseases as well as reagents and systems for diagnostic purposes in transfusion and transplantation medicine. Biotest is, in addition, one of the leading manufacturers of products for the hygiene monitoring of air and work surfaces.

The most important starting material for our pharmaceutical products is human blood plasma which we process into effective and highly pure medicinal products in one of the world’s most modern production facilities in Europe. Our products are used in the treatment of life-threatening diseases such as coagulation disorders (haemophilia), severe infections or disorders of the immune system. One of our highest priority research projects is the development of monoclonal antibodies, active substances produced by biotechnological techniques, which will open up new prospects in the treatment of rheumatism, leukaemia and other autoimmune diseases.

Biotest products meet the highest standards and are sold in markets which have to satisfy the most stringent registration requirements in the world. Patients, hospitals, medical practices, laboratories and companies in 159 countries around the globe put their trust in Biotest’s quality and safety.